万代 昌紀

Last Update: 2020/07/14 11:44:52

Print

Name(Kanji/Kana/Abecedarium Latinum)
万代 昌紀/マンダイ マサキ/Mandai, Masaki
Primary Affiliation(Org1/Job title)
Graduate Schools Medicine/Professor
Faculty
Org1 Job title
医学部 Senior Lecturer/ Junior Associate Professor
Academic Organizations You are Affiliated to in Japan
Organization name(Japanese) Organization name(English)
日本産科婦人科学会 日本婦人科腫瘍学会
日本癌学会 日本免疫学会
日本癌治療学会 日本産婦人科手術学会
日本産婦人科内視鏡学会 日本エンドメトリオーシス学会
日本内視鏡外科学会
Academic Organizations Overaseas You are Affiliated to
Organization name Country
American Society of Clinical Oncology USA
Academic Degree
Field(Japanese) Field(English) University(Japanese) University(English) Method
博士(医学) 京都大学
Undergraduate School / Major(s)
University(Japanese) University(English) Faculty(Japanese) Faculty(English) Major(s)(Japanese) Major(s)(English) Degree
京都大学 医学部医学進学課程 修了
京都大学 医学部医学科 卒業
Work Experience
Period Organization(Japanese) Organization(English) Job title(Japanese) Job title(English)
1988/04/04-1989/01/31 京都大学医学部附属病院 kyoto university hospital 医員
1989/02/01-1992/05/31 兵庫県立尼崎病院 Hyogo pref. Amagasaki Hospital 医員
1992/06/01-2000/10/31 京都大学医学部附属病院 kyoto university hospital 医員、助手
2000/11/01-2001/12/31 米国国立衛生研究所ワクチンリサーチセンター NIH 研究員
2002/12/1-2012/12/31 京都大学医学部附属病院 kyoto university hospital 助手、講師
2013/01/01-2017/02/28 近大学医学部産科婦人科学教室 kindai university hospital 教授 professor
2017/03/01- 京都大学大学院医学研究科婦人科学産科学 kyoto university graduate school of medicine, gynecology and obstetrics 教授 professor
Language of Instruction
Language(japanese) Language(english) Code
日本語 Japanese jpn
英語 English eng
researchmap URL
https://researchmap.jp/read0046826
Research Topics
(Japanese)
婦人科がんの新規治療に関する研究、特に卵巣癌に対する免疫療法、分子標的治療、個別化治療 2)婦人科がんの分子生物学的解析、特にゲノムワイド解析とAIを用いた解析
(English)
Cancer treatment in gynecologic field, especially cancer immunotherapy, molecular target therapy and precision medicine. 2) Gynecologic cancer biology including comprehensive genome-wide analysis and AI analysis
Overview of the research
(Japanese)
これまで20年間以上にわたって婦人科がん、特に卵巣がんの免疫学的解析をおこなってきた。この成果を生かしてトランスレーショナルリサーチとして、世界で初めて卵巣癌に対する抗PD-1抗体を用いた免疫療法の医師主導治験をおこない、その効果を報告した。現在、ゲノムワイド解析を通じて、婦人科がんの腫瘍免疫の状態を評価する方法の開発を進めており、AIによる機械学習も取り入れつつ、包括的な解析手段の確立を目指している。
(English)
I have been studying gynecologic cancer biology for more than 20 years. One of my specialties is cancer immunology, which I started from 2000 in NIH. I launched immunotherapy project for ginecologic cancer, and conducted first in the world clinical trial using anti-PD-1 antibody for recurrent ovarian cancer. Besides, I have conducted various analysis to associate cancer imunology and genome-wide analysis in gynecologic cancers. Recently, I am also trying to apply machine learning for comprehensive analysis of immunological status of each gynecologic cancer case.
Fields of research (key words)
Key words(Japanese) Key words(English)
婦人科腫瘍学 gynecologic oncology
Published Papers
Author Author(Japanese) Author(English) Title Title(Japanese) Title(English) Bibliography Bibliography(Japanese) Bibliography(English) Publication date Refereed paper Language Publishing type Disclose
万代 昌紀 万代 昌紀 Takamatsu S, Murakami K, Takaya H, Tobiume T, Nakai H, Suzuki A, Mandai M, Matsumura N. Malignant psoas syndrome associated with gynecological malignancy: Three case reports and a review of the literature. Mol Clin Oncol. 2018 Jul;9(1):82-86. Takamatsu S, Murakami K, Takaya H, Tobiume T, Nakai H, Suzuki A, Mandai M, Matsumura N. Malignant psoas syndrome associated with gynecological malignancy: Three case reports and a review of the literature. Mol Clin Oncol. 2018 Jul;9(1):82-86. Refereed Disclose to all
万代 昌紀 万代 昌紀 Taha AAA, Koshiyama M, Matsumura N, Abiko K, Yamaguchi K, Hamanishi J, Baba T, Kharma B, Mohamed IH, Ameen MM, Ismail SA, Konishi I, Mandai M. The effect of the type of dietary protein on the development of ovarian cancer. Oncotarget. 2018 May 8;9(35):239 Taha AAA, Koshiyama M, Matsumura N, Abiko K, Yamaguchi K, Hamanishi J, Baba T, Kharma B, Mohamed IH, Ameen MM, Ismail SA, Konishi I, Mandai M. The effect of the type of dietary protein on the development of ovarian cancer. Oncotarget. 2018 May 8;9(35):239 Refereed Disclose to all
万代 昌紀 万代 昌紀 Taki M, Abiko K, Baba T, Hamanishi J, Yamaguchi K, Murakami R, Yamanoi K, Horikawa N, Hosoe Y, Nakamura E, Sugiyama A, Mandai M, Konishi I, Matsumura N. Snail promotes ovarian cancer progression by recruiting myeloid-derived suppressor cells via CXCR2 lig Taki M, Abiko K, Baba T, Hamanishi J, Yamaguchi K, Murakami R, Yamanoi K, Horikawa N, Hosoe Y, Nakamura E, Sugiyama A, Mandai M, Konishi I, Matsumura N. Snail promotes ovarian cancer progression by recruiting myeloid-derived suppressor cells via CXCR2 lig Refereed Disclose to all
万代 昌紀 万代 昌紀 Kuwahara R, Kido A, Tanaka S, Abiko K, Nakao K, Himoto Y, Nishio N, Kurata Y, Mandai M, Togashi K. A Predictor of Tumor Recurrence in Patients With Endometrial Carcinoma After Complete Resection of the Tumor: The Role of Pretreatment Apparent Diffusion Co Kuwahara R, Kido A, Tanaka S, Abiko K, Nakao K, Himoto Y, Nishio N, Kurata Y, Mandai M, Togashi K. A Predictor of Tumor Recurrence in Patients With Endometrial Carcinoma After Complete Resection of the Tumor: The Role of Pretreatment Apparent Diffusion Co Refereed Disclose to all
万代 昌紀 万代 昌紀 Sato M, Kondoh E, Iwao T, Hiragi S, Okamoto K, Tamura H, Mogami H, Chigusa Y, Kuroda T, Mandai M, Konishi I, Kato G. Nationwide survey of severe postpartum hemorrhage in Japan: an exploratory study using the national database of health insurance claims. J Sato M, Kondoh E, Iwao T, Hiragi S, Okamoto K, Tamura H, Mogami H, Chigusa Y, Kuroda T, Mandai M, Konishi I, Kato G. Nationwide survey of severe postpartum hemorrhage in Japan: an exploratory study using the national database of health insurance claims. J Refereed Disclose to all
万代 昌紀 万代 昌紀 Takaya H, Nakai H, Murakami K, Tobiume T, Suzuki A, Mandai M, Matsumura N. Efficacy of weekly administration of paclitaxel and carboplatin for advanced ovarian cancer patients with poor performance status. Int J Clin Oncol. 2018 Aug;23(4):698-706. Takaya H, Nakai H, Murakami K, Tobiume T, Suzuki A, Mandai M, Matsumura N. Efficacy of weekly administration of paclitaxel and carboplatin for advanced ovarian cancer patients with poor performance status. Int J Clin Oncol. 2018 Aug;23(4):698-706. Refereed Disclose to all
万代 昌紀 万代 昌紀 Matsuda Y, Chigusa Y, Kondoh E, Ito I, Ueda Y, Mandai M. A Case of Macrolide-Refractory Mycoplasma pneumoniae Pneumonia in Pregnancy Treated with Garenoxacin. Case Rep Obstet Gynecol. 2017;2017:3520192. Matsuda Y, Chigusa Y, Kondoh E, Ito I, Ueda Y, Mandai M. A Case of Macrolide-Refractory Mycoplasma pneumoniae Pneumonia in Pregnancy Treated with Garenoxacin. Case Rep Obstet Gynecol. 2017;2017:3520192. Refereed Disclose to all
万代 昌紀 万代 昌紀 Lin H, Wei S, Hurt EM, Green MD, Zhao L, Vatan L, Szeliga W, Herbst R, Harms PW, Fecher LA, Vats P, Chinnaiyan AM, Lao CD, Lawrence TS, Wicha M, Hamanishi J, Mandai M, Kryczek I, Zou W. Host expression of PD-L1 determines efficacy of PD-L1 pathway blockad Lin H, Wei S, Hurt EM, Green MD, Zhao L, Vatan L, Szeliga W, Herbst R, Harms PW, Fecher LA, Vats P, Chinnaiyan AM, Lao CD, Lawrence TS, Wicha M, Hamanishi J, Mandai M, Kryczek I, Zou W. Host expression of PD-L1 determines efficacy of PD-L1 pathway blockad Refereed Disclose to all
万代 昌紀 万代 昌紀 Kotani Y, Tobiume T, Fujishima R, Shigeta M, Takaya H, Nakai H, Suzuki A, Tsuji I, Mandai M, Matsumura N. Recurrence of uterine myoma after myomectomy: Open myomectomy versus laparoscopic myomectomy. J Obstet Gynaecol Res. 2018 Feb;44(2):298-302. Kotani Y, Tobiume T, Fujishima R, Shigeta M, Takaya H, Nakai H, Suzuki A, Tsuji I, Mandai M, Matsumura N. Recurrence of uterine myoma after myomectomy: Open myomectomy versus laparoscopic myomectomy. J Obstet Gynaecol Res. 2018 Feb;44(2):298-302. Refereed Disclose to all
万代 昌紀 万代 昌紀 Egawa-Takata T, Ueda Y, Morimoto A, Tanaka Y, Yagi A, Terai Y, Ohmichi M, Ichimura T, Sumi T, Murata H, Okada H, Nakai H, Mandai M, Matsuzaki S, Kobayashi E, Yoshino K, Kimura T, Saito J, Hori Y, Morii E, Nakayama T, Asai-Sato M, Miyagi E, Sekine M, Enomo Egawa-Takata T, Ueda Y, Morimoto A, Tanaka Y, Yagi A, Terai Y, Ohmichi M, Ichimura T, Sumi T, Murata H, Okada H, Nakai H, Mandai M, Matsuzaki S, Kobayashi E, Yoshino K, Kimura T, Saito J, Hori Y, Morii E, Nakayama T, Asai-Sato M, Miyagi E, Sekine M, Enomo Refereed Disclose to all
万代 昌紀 万代 昌紀 Murakami R, Matsumura N, Brown JB, Higasa K, Tsutsumi T, Kamada M, Abou-Taleb H, Hosoe Y, Kitamura S, Yamaguchi K, Abiko K, Hamanishi J, Baba T, Koshiyama M, Okuno Y, Yamada R, Matsuda F, Konishi I, Mandai M. Exome Sequencing Landscape Analysis in Ovarian Murakami R, Matsumura N, Brown JB, Higasa K, Tsutsumi T, Kamada M, Abou-Taleb H, Hosoe Y, Kitamura S, Yamaguchi K, Abiko K, Hamanishi J, Baba T, Koshiyama M, Okuno Y, Yamada R, Matsuda F, Konishi I, Mandai M. Exome Sequencing Landscape Analysis in Ovarian Refereed Disclose to all
万代 昌紀 万代 昌紀 Pujade-Lauraine E, Ledermann JA, Selle F, Gebski V, Penson RT, Oza AM, Korach J, Huzarski T, Poveda A, Pignata S, Friedlander M, Colombo N, Harter P, Fujiwara K, Ray-Coquard I, Banerjee S, Liu J, Lowe ES, Bloomfield R, Pautier P; SOLO2/ENGOT-Ov21 investig Pujade-Lauraine E, Ledermann JA, Selle F, Gebski V, Penson RT, Oza AM, Korach J, Huzarski T, Poveda A, Pignata S, Friedlander M, Colombo N, Harter P, Fujiwara K, Ray-Coquard I, Banerjee S, Liu J, Lowe ES, Bloomfield R, Pautier P; SOLO2/ENGOT-Ov21 investig Refereed Disclose to all
万代 昌紀 万代 昌紀 Sakai K, Ukita M, Schmidt J, Wu L, De Velasco MA, Roter A, Jevons L, Nishio K, Mandai M. Clonal composition of human ovarian cancer based on copy number analysis reveals a reciprocal relation with oncogenic mutation status. Cancer Lett. 2017 Oct 1;405:22- Sakai K, Ukita M, Schmidt J, Wu L, De Velasco MA, Roter A, Jevons L, Nishio K, Mandai M. Clonal composition of human ovarian cancer based on copy number analysis reveals a reciprocal relation with oncogenic mutation status. Cancer Lett. 2017 Oct 1;405:22- Refereed Disclose to all
万代 昌紀 万代 昌紀 Yagi A, Ueda Y, Egawa-Takata T, Tanaka Y, Nakae R, Morimoto A, Terai Y, Ohmichi M, Ichimura T, Sumi T, Murata H, Okada H, Nakai H, Mandai M, Matsuzaki S, Kobayashi E, Yoshino K, Kimura T, Saito J, Hori Y, Morii E, Nakayama T, Suzuki Y, Motoki Y, Sukegawa Yagi A, Ueda Y, Egawa-Takata T, Tanaka Y, Nakae R, Morimoto A, Terai Y, Ohmichi M, Ichimura T, Sumi T, Murata H, Okada H, Nakai H, Mandai M, Matsuzaki S, Kobayashi E, Yoshino K, Kimura T, Saito J, Hori Y, Morii E, Nakayama T, Suzuki Y, Motoki Y, Sukegawa Refereed Disclose to all
万代 昌紀 万代 昌紀 Sakae C, Yamaguchi K, Matsumura N, Nakai H, Yoshioka Y, Kondoh E, Hamanishi J, Abiko K, Koshiyama M, Baba T, Kido A, Mandai M, Konishi I. Groin lymph node detection and sentinel lymph node biopsy in vulvar cancer. J Gynecol Oncol. 2016 Nov;27(6):e57. Sakae C, Yamaguchi K, Matsumura N, Nakai H, Yoshioka Y, Kondoh E, Hamanishi J, Abiko K, Koshiyama M, Baba T, Kido A, Mandai M, Konishi I. Groin lymph node detection and sentinel lymph node biopsy in vulvar cancer. J Gynecol Oncol. 2016 Nov;27(6):e57. Refereed Disclose to all
万代 昌紀 万代 昌紀 Yagi A, Ueda Y, Egawa-Takata T, Tanaka Y, Morimoto A, Terai Y, Ohmichi M, Ichimura T, Sumi T, Murata H, Okada H, Nakai H, Mandai M, Yoshino K, Kimura T, Saito J, Kudoh R, Sekine M, Enomoto T, Hirai K, Horikoshi Y, Takagi T, Shimura K. Development of an ef Yagi A, Ueda Y, Egawa-Takata T, Tanaka Y, Morimoto A, Terai Y, Ohmichi M, Ichimura T, Sumi T, Murata H, Okada H, Nakai H, Mandai M, Yoshino K, Kimura T, Saito J, Kudoh R, Sekine M, Enomoto T, Hirai K, Horikoshi Y, Takagi T, Shimura K. Development of an ef Refereed Disclose to all
万代 昌紀 万代 昌紀 Yagi A, Ueda Y, Egawa-Takata T, Tanaka Y, Terai Y, Ohmichi M, Ichimura T, Sumi T, Murata H, Okada H, Nakai H, Mandai M, Matsuzaki S, Kobayashi E, Yoshino K, Kimura T, Saito J, Hori Y, Morii E, Nakayama T, Suzuki Y, Motoki Y, Sukegawa A, Asai-Sato M, Miyag Yagi A, Ueda Y, Egawa-Takata T, Tanaka Y, Terai Y, Ohmichi M, Ichimura T, Sumi T, Murata H, Okada H, Nakai H, Mandai M, Matsuzaki S, Kobayashi E, Yoshino K, Kimura T, Saito J, Hori Y, Morii E, Nakayama T, Suzuki Y, Motoki Y, Sukegawa A, Asai-Sato M, Miyag Refereed Disclose to all
万代 昌紀 万代 昌紀 Tobiume T, Kotani Y, Takaya H, Nakai H, Tsuji I, Suzuki A, Mandai M. Determinant factors of postoperative recurrence of endometriosis: difference between endometrioma and pain. Eur J Obstet Gynecol Reprod Biol. 2016 Oct;205:54-9. Tobiume T, Kotani Y, Takaya H, Nakai H, Tsuji I, Suzuki A, Mandai M. Determinant factors of postoperative recurrence of endometriosis: difference between endometrioma and pain. Eur J Obstet Gynecol Reprod Biol. 2016 Oct;205:54-9. Refereed Disclose to all
万代 昌紀 万代 昌紀 Abou-Taleb H, Yamaguchi K, Matsumura N, Murakami R, Nakai H, Higasa K, Amano Y, Abiko K, Yoshioka Y, Hamanishi J, Koshiyama M, Baba T, Yamada R, Matsuda F, Konishi I, Mandai M. Comprehensive assessment of the expression of the SWI/SNF complex defines two Abou-Taleb H, Yamaguchi K, Matsumura N, Murakami R, Nakai H, Higasa K, Amano Y, Abiko K, Yoshioka Y, Hamanishi J, Koshiyama M, Baba T, Yamada R, Matsuda F, Konishi I, Mandai M. Comprehensive assessment of the expression of the SWI/SNF complex defines two Refereed Disclose to all
万代 昌紀 万代 昌紀 Yamanoi K, Matsumura N, Murphy SK, Baba T, Abiko K, Hamanishi J, Yamaguchi K, Koshiyama M, Konishi I, Mandai M. Suppression of ABHD2, identified through a functional genomics screen, causes anoikis resistance, chemoresistance and poor prognosis in ovaria Yamanoi K, Matsumura N, Murphy SK, Baba T, Abiko K, Hamanishi J, Yamaguchi K, Koshiyama M, Konishi I, Mandai M. Suppression of ABHD2, identified through a functional genomics screen, causes anoikis resistance, chemoresistance and poor prognosis in ovaria Refereed Disclose to all
万代 昌紀 万代 昌紀 Murakami K, Nakai H, Aoki M, Takaya H, Ukita M, Kotani Y, Shimaoka M, Tobiume T, Tsuji I, Suzuki A, Mandai M. Ultrasonic scalpel ablation for vaginal intraepithelial neoplasia occurring after hysterectomy. Eur J Gynaecol Oncol. 2016 in press Murakami K, Nakai H, Aoki M, Takaya H, Ukita M, Kotani Y, Shimaoka M, Tobiume T, Tsuji I, Suzuki A, Mandai M. Ultrasonic scalpel ablation for vaginal intraepithelial neoplasia occurring after hysterectomy. Eur J Gynaecol Oncol. 2016 in press Refereed Disclose to all
万代 昌紀 万代 昌紀 Hamanishi J, Mandai M, Konishi I. Immune checkpoint inhibition in ovarian cancer. Int Immunol. 2016 [Epub ahead of print] Hamanishi J, Mandai M, Konishi I. Immune checkpoint inhibition in ovarian cancer. Int Immunol. 2016 [Epub ahead of print] Refereed Disclose to all
万代 昌紀 万代 昌紀 Mandai M, Hamanishi J, Abiko K, Matsumura N, Baba T, Konishi I. Dual Faces of IFNγ in Cancer Progression: A Role of PD-L1 Induction in the Determination of Pro- and Antitumor Immunity. Clin Cancer Res. 2016 May 15;22(10):2329-34. Mandai M, Hamanishi J, Abiko K, Matsumura N, Baba T, Konishi I. Dual Faces of IFNγ in Cancer Progression: A Role of PD-L1 Induction in the Determination of Pro- and Antitumor Immunity. Clin Cancer Res. 2016 May 15;22(10):2329-34. Refereed Disclose to all
万代 昌紀 万代 昌紀 Murakami R, Matsumura N, Brown JB, Wang Z, Yamaguchi K, Abiko K, Yoshioka Y, Hamanishi J, Baba T, Koshiyama M, Mandai M, Yamada R, Konishi I. Prediction of taxane and platinum sensitivity in ovarian cancer based on gene expression profiles. Gynecol Oncol. Murakami R, Matsumura N, Brown JB, Wang Z, Yamaguchi K, Abiko K, Yoshioka Y, Hamanishi J, Baba T, Koshiyama M, Mandai M, Yamada R, Konishi I. Prediction of taxane and platinum sensitivity in ovarian cancer based on gene expression profiles. Gynecol Oncol. Refereed Disclose to all
万代 昌紀 万代 昌紀 Murakami R, Matsumura N, Mandai M, Yoshihara K, Tanabe H, Nakai H, Yamanoi K, Abiko K, Yoshioka Y, Hamanishi J, Yamaguchi K, Baba T, Koshiyama M, Enomoto T, Okamoto A, Murphy SK, Mori S, Mikami Y, Minamiguchi S, Konishi I. Establishment of a Novel Histopa Murakami R, Matsumura N, Mandai M, Yoshihara K, Tanabe H, Nakai H, Yamanoi K, Abiko K, Yoshioka Y, Hamanishi J, Yamaguchi K, Baba T, Koshiyama M, Enomoto T, Okamoto A, Murphy SK, Mori S, Mikami Y, Minamiguchi S, Konishi I. Establishment of a Novel Histopa Refereed Disclose to all
万代 昌紀 万代 昌紀 Egawa-Takata T, Ueda Y, Tanaka Y, Morimoto A, Kubota S, Yagi A, Terai Y, Ohmichi M, Ichimura T, Sumi T, Murata H, Okada H, Nakai H, Mandai M, Yoshino K, Kimura T, Saito J, Kudo R, Sekine M, Enomoto T, Horikoshi Y, Takagi T, Shimura K. Mothers' attitudes i Egawa-Takata T, Ueda Y, Tanaka Y, Morimoto A, Kubota S, Yagi A, Terai Y, Ohmichi M, Ichimura T, Sumi T, Murata H, Okada H, Nakai H, Mandai M, Yoshino K, Kimura T, Saito J, Kudo R, Sekine M, Enomoto T, Horikoshi Y, Takagi T, Shimura K. Mothers' attitudes i Refereed Disclose to all
万代 昌紀 万代 昌紀 Mandai M, Hamanishi J, Abiko K, Matsumura N, Baba T, Konishi I. Anti-PD-L1/PD-1 immune therapies in ovarian cancer: basic mechanism and future clinical application. Int J Clin Oncol. 2016 Jun;21(3):456-61. Mandai M, Hamanishi J, Abiko K, Matsumura N, Baba T, Konishi I. Anti-PD-L1/PD-1 immune therapies in ovarian cancer: basic mechanism and future clinical application. Int J Clin Oncol. 2016 Jun;21(3):456-61. Refereed Disclose to all
万代 昌紀 万代 昌紀 Hamanishi J, Mandai M, Matsumura N, Abiko K, Baba T, Konishi I. PD-1/PD-L1 blockade in cancer treatment: perspectives and issues. Int J Clin Oncol. 2016 Jun;21(3):462-73 Hamanishi J, Mandai M, Matsumura N, Abiko K, Baba T, Konishi I. PD-1/PD-L1 blockade in cancer treatment: perspectives and issues. Int J Clin Oncol. 2016 Jun;21(3):462-73 Refereed Disclose to all
万代 昌紀 万代 昌紀 Ukita M, Aoki M, Murakami K, Takaya H, Kotani Y, Shimaoka M, Tobiume T, Nakai H, Tsuji I, Suzuki A, Mandai M. Nontuberculous Mycobacterial Infection in the Uterine Cervix Mimics Invasive Cervical Cancer in Immunocompetent Woman. Int J Gynecol Pathol. 2016 Ukita M, Aoki M, Murakami K, Takaya H, Kotani Y, Shimaoka M, Tobiume T, Nakai H, Tsuji I, Suzuki A, Mandai M. Nontuberculous Mycobacterial Infection in the Uterine Cervix Mimics Invasive Cervical Cancer in Immunocompetent Woman. Int J Gynecol Pathol. 2016 Refereed Disclose to all
万代 昌紀 万代 昌紀 Tsuji I, Fujinami N, Kotani Y, Tobiume T, Aoki M, Murakami K, Kanto A, Takaya H, Ukita M, Shimaoka M, Nakai H, Suzuki A, Mandai M. Reproductive Outcome of Infertile Patients with Fibroids Based on the Patient and Fibroid Characteristics; Optimal and Perso Tsuji I, Fujinami N, Kotani Y, Tobiume T, Aoki M, Murakami K, Kanto A, Takaya H, Ukita M, Shimaoka M, Nakai H, Suzuki A, Mandai M. Reproductive Outcome of Infertile Patients with Fibroids Based on the Patient and Fibroid Characteristics; Optimal and Perso Refereed Disclose to all
万代 昌紀 万代 昌紀 Peng J, Yoshioka Y, Mandai M, Matsumura N, Baba T, Yamaguchi K, Hamanishi J, Kharma B, Murakami R, Abiko K, Murphy SK, Konishi I. The BMP signaling pathway leads to enhanced proliferation in serous ovarian cancer-A potential therapeutic target. Mol Carcin Peng J, Yoshioka Y, Mandai M, Matsumura N, Baba T, Yamaguchi K, Hamanishi J, Kharma B, Murakami R, Abiko K, Murphy SK, Konishi I. The BMP signaling pathway leads to enhanced proliferation in serous ovarian cancer-A potential therapeutic target. Mol Carcin Refereed Disclose to all
万代 昌紀 万代 昌紀 Peng J, Hamanishi J, Matsumura N, Abiko K, Murat K, Baba T, Yamaguchi K, Horikawa N, Hosoe Y, Murphy SK, Konishi I, Mandai M. Chemotherapy Induces Programmed Cell Death-Ligand 1 Overexpression via the Nuclear Factor-κB to Foster an Immunosuppressive Tumor Peng J, Hamanishi J, Matsumura N, Abiko K, Murat K, Baba T, Yamaguchi K, Horikawa N, Hosoe Y, Murphy SK, Konishi I, Mandai M. Chemotherapy Induces Programmed Cell Death-Ligand 1 Overexpression via the Nuclear Factor-κB to Foster an Immunosuppressive Tumor Refereed Disclose to all
万代 昌紀 万代 昌紀 Mandai M, Amano Y, Yamaguchi K, Matsumura N, Baba T, Konishi I. Ovarian clear cell carcinoma meets metabolism; HNF-1β confers survival benefits through the Warburg effect and ROS reduction. Oncotarget. 2015 Oct 13;6(31):30704-14. Mandai M, Amano Y, Yamaguchi K, Matsumura N, Baba T, Konishi I. Ovarian clear cell carcinoma meets metabolism; HNF-1β confers survival benefits through the Warburg effect and ROS reduction. Oncotarget. 2015 Oct 13;6(31):30704-14. Refereed Disclose to all
万代 昌紀 万代 昌紀 Hamanishi J, Mandai M, Ikeda T, Minami M, Kawaguchi A, Murayama T, Kanai M, Mori Y, Matsumoto S, Chikuma S, Matsumura N, Abiko K, Baba T, Yamaguchi K, Ueda A, Hosoe Y, Morita S, Yokode M, Shimizu A, Honjo T, Konishi I. Safety and Antitumor Activity of Ant Hamanishi J, Mandai M, Ikeda T, Minami M, Kawaguchi A, Murayama T, Kanai M, Mori Y, Matsumoto S, Chikuma S, Matsumura N, Abiko K, Baba T, Yamaguchi K, Ueda A, Hosoe Y, Morita S, Yokode M, Shimizu A, Honjo T, Konishi I. Safety and Antitumor Activity of Ant Refereed Disclose to all
万代 昌紀 万代 昌紀 Amano Y, Mandai M, Yamaguchi K, Matsumura N, Kharma B, Baba T, Abiko K, Hamanishi J, Yoshioka Y, Konishi I. Metabolic alterations caused by HNF1β expression in ovarian clear cell carcinoma contribute to cell survival. Oncotarget. 2015 Sep 22;6(28):26002-1 Amano Y, Mandai M, Yamaguchi K, Matsumura N, Kharma B, Baba T, Abiko K, Hamanishi J, Yoshioka Y, Konishi I. Metabolic alterations caused by HNF1β expression in ovarian clear cell carcinoma contribute to cell survival. Oncotarget. 2015 Sep 22;6(28):26002-1 Refereed Disclose to all
万代 昌紀 万代 昌紀 Yasuda Y, Fujita M, Koike E, Obata K, Shiota M, Kotani Y, Musha T, Tsuji-Kawahara S, Satou T, Masuda S, Okano J, Yamasaki H, Okumoto K, Uesugi T, Nakao S, Hoshiai H, Mandai M. Erythropoietin Receptor Antagonist Suppressed Ectopic Hemoglobin Synthesis in X Yasuda Y, Fujita M, Koike E, Obata K, Shiota M, Kotani Y, Musha T, Tsuji-Kawahara S, Satou T, Masuda S, Okano J, Yamasaki H, Okumoto K, Uesugi T, Nakao S, Hoshiai H, Mandai M. Erythropoietin Receptor Antagonist Suppressed Ectopic Hemoglobin Synthesis in X Refereed Disclose to all
万代 昌紀 万代 昌紀 Abiko K, Matsumura N, Hamanishi J, Horikawa N, Murakami R, Yamaguchi K, Yoshioka Y, Baba T, Konishi I, Mandai M. IFN-γ from lymphocytes induces PD-L1 expression and promotes progression of ovarian cancer. Br J Cancer. 2015 Apr 28;112(9):1501-9. Abiko K, Matsumura N, Hamanishi J, Horikawa N, Murakami R, Yamaguchi K, Yoshioka Y, Baba T, Konishi I, Mandai M. IFN-γ from lymphocytes induces PD-L1 expression and promotes progression of ovarian cancer. Br J Cancer. 2015 Apr 28;112(9):1501-9. Refereed Disclose to all
万代 昌紀 万代 昌紀 Nagura M, Matsumura N, Baba T, Murakami R, Kharma B, Hamanishi J, Yamaguchi K, Abiko K, Koshiyama M, Mandai M, Murata T, Murphy SK, Konishi I. Invasion of uterine cervical squamous cell carcinoma cells is facilitated by locoregional interaction with cance Nagura M, Matsumura N, Baba T, Murakami R, Kharma B, Hamanishi J, Yamaguchi K, Abiko K, Koshiyama M, Mandai M, Murata T, Murphy SK, Konishi I. Invasion of uterine cervical squamous cell carcinoma cells is facilitated by locoregional interaction with cance Refereed Disclose to all
万代 昌紀 万代 昌紀 Morimoto A, Ueda Y, Egawa-Takata T, Yagi A, Terai Y, Ohmichi M, Ichimura T, Sumi T, Murata H, Kanzaki H, Nakai H, Mandai M, Yoshino K, Fujita M, Kimura T, Saito J, Sobue T, Nishikawa N, Sekine M, Enomoto T, Horikoshi Y, Takagi T. Effect on HPV vaccination Morimoto A, Ueda Y, Egawa-Takata T, Yagi A, Terai Y, Ohmichi M, Ichimura T, Sumi T, Murata H, Kanzaki H, Nakai H, Mandai M, Yoshino K, Fujita M, Kimura T, Saito J, Sobue T, Nishikawa N, Sekine M, Enomoto T, Horikoshi Y, Takagi T. Effect on HPV vaccination Refereed Disclose to all
万代 昌紀 万代 昌紀 Baba T, Kang HS, Hosoe Y, Kharma B, Abiko K, Matsumura N, Hamanishi J, Yamaguchi K, Yoshioka Y, Koshiyama M, Mandai M, Murphy SK, Konishi I. Menstrual cyclic change of metastin/GPR54 in endometrium. Med Mol Morphol. 2015 Jun;48(2):76-84. Baba T, Kang HS, Hosoe Y, Kharma B, Abiko K, Matsumura N, Hamanishi J, Yamaguchi K, Yoshioka Y, Koshiyama M, Mandai M, Murphy SK, Konishi I. Menstrual cyclic change of metastin/GPR54 in endometrium. Med Mol Morphol. 2015 Jun;48(2):76-84. Refereed Disclose to all
万代 昌紀 万代 昌紀 Okamoto T, Mandai M, Matsumura N, Yamaguchi K, Kondoh H, Amano Y, Baba T, Hamanishi J, Abiko K, Kosaka K, Murphy SK, Mori S, Konishi I. Hepatocyte nuclear factor-1β (HNF-1β) promotes glucose uptake and glycolytic activity in ovarian clear cell carcinoma. Okamoto T, Mandai M, Matsumura N, Yamaguchi K, Kondoh H, Amano Y, Baba T, Hamanishi J, Abiko K, Kosaka K, Murphy SK, Mori S, Konishi I. Hepatocyte nuclear factor-1β (HNF-1β) promotes glucose uptake and glycolytic activity in ovarian clear cell carcinoma. Refereed Disclose to all
万代 昌紀 万代 昌紀 Ukita M, Nakai H, Kotani Y, Tobiume T, Koike E, Tsuji I, Suzuki A, Mandai M. Long-term survival in metastatic malignant struma ovarii treated with oral chemotherapy: A case report. Oncol Lett. 2014 Dec;8(6):2458-2462. Ukita M, Nakai H, Kotani Y, Tobiume T, Koike E, Tsuji I, Suzuki A, Mandai M. Long-term survival in metastatic malignant struma ovarii treated with oral chemotherapy: A case report. Oncol Lett. 2014 Dec;8(6):2458-2462. Refereed Disclose to all
万代 昌紀 万代 昌紀 Kharma B, Baba T, Matsumura N, Kang HS, Hamanishi J, Murakami R, McConechy MM, Leung S, Yamaguchi K, Hosoe Y, Yoshioka Y, Murphy SK, Mandai M, Huntsman DG, Konishi I. STAT1 drives tumor progression in serous papillary endometrial cancer. Cancer Res. 2014 Kharma B, Baba T, Matsumura N, Kang HS, Hamanishi J, Murakami R, McConechy MM, Leung S, Yamaguchi K, Hosoe Y, Yoshioka Y, Murphy SK, Mandai M, Huntsman DG, Konishi I. STAT1 drives tumor progression in serous papillary endometrial cancer. Cancer Res. 2014 Refereed Disclose to all
万代 昌紀 万代 昌紀 Yamaguchi K, Matsumura N, Mandai M, Baba T, Konishi I, Murphy SK. Epigenetic and genetic dispositions of ovarian carcinomas. Oncoscience. 2014 Sep 22;1(9):574-9. Yamaguchi K, Matsumura N, Mandai M, Baba T, Konishi I, Murphy SK. Epigenetic and genetic dispositions of ovarian carcinomas. Oncoscience. 2014 Sep 22;1(9):574-9. Refereed Disclose to all
万代 昌紀 万代 昌紀 Yamaguchi K, Huang Z, Matsumura N, Mandai M, Okamoto T, Baba T, Konishi I, Berchuck A, Murphy SK. Epigenetic determinants of ovarian clear cell carcinoma biology. Int J Cancer. 2014 Aug 1;135(3):585-97. Yamaguchi K, Huang Z, Matsumura N, Mandai M, Okamoto T, Baba T, Konishi I, Berchuck A, Murphy SK. Epigenetic determinants of ovarian clear cell carcinoma biology. Int J Cancer. 2014 Aug 1;135(3):585-97. Refereed Disclose to all
万代 昌紀 万代 昌紀 Takamatsu S, Matsumura N, Baba T, Mandai M, Mikami Y, Konishi I. Humoral hypercalcemia caused by uterine corpus carcinosarcoma consisting of squamous cell carcinoma in its epithelial component. J Obstet Gynaecol Res. 2014 Jan;40(1):263-7 Takamatsu S, Matsumura N, Baba T, Mandai M, Mikami Y, Konishi I. Humoral hypercalcemia caused by uterine corpus carcinosarcoma consisting of squamous cell carcinoma in its epithelial component. J Obstet Gynaecol Res. 2014 Jan;40(1):263-7 Refereed Disclose to all
万代 昌紀 万代 昌紀 Amano Y, Mandai M, Baba T, Hamanishi J, Yoshioka Y, Matsumura N, Konishi I. Recurrence of a carcinoid tumor of the ovary 13 years after the primary surgery: A case report. Oncol Lett. 2013 Nov;6(5):1241-1244. Amano Y, Mandai M, Baba T, Hamanishi J, Yoshioka Y, Matsumura N, Konishi I. Recurrence of a carcinoid tumor of the ovary 13 years after the primary surgery: A case report. Oncol Lett. 2013 Nov;6(5):1241-1244. Refereed Disclose to all
万代 昌紀 万代 昌紀 Tan TZ, Miow QH, Huang RY, Wong MK, Ye J, Lau JA, Wu MC, Bin Abdul Hadi LH, Soong R, Choolani M, Davidson B, Nesland JM, Wang LZ, Matsumura N, Mandai M, Konishi I, Goh BC, Chang JT, Thiery JP, Mori S. Functional genomics identifies five distinct molecular Tan TZ, Miow QH, Huang RY, Wong MK, Ye J, Lau JA, Wu MC, Bin Abdul Hadi LH, Soong R, Choolani M, Davidson B, Nesland JM, Wang LZ, Matsumura N, Mandai M, Konishi I, Goh BC, Chang JT, Thiery JP, Mori S. Functional genomics identifies five distinct molecular Refereed Disclose to all
万代 昌紀 万代 昌紀 Kharma B, Baba T, Mandai M, Matsumura N, Murphy SK, Kang HS, Yamanoi K, Hamanishi J, Yamaguchi K, Yoshioka Y, Konishi I. Utilization of genomic signatures to identify high-efficacy candidate drugs for chemorefractory endometrial cancers. Int J Cancer. 201 Kharma B, Baba T, Mandai M, Matsumura N, Murphy SK, Kang HS, Yamanoi K, Hamanishi J, Yamaguchi K, Yoshioka Y, Konishi I. Utilization of genomic signatures to identify high-efficacy candidate drugs for chemorefractory endometrial cancers. Int J Cancer. 201 Refereed Disclose to all
万代 昌紀 万代 昌紀 Abiko K, Mandai M, Hamanishi J, Yoshioka Y, Matsumura N, Baba T, Yamaguchi K, Murakami R, Yamamoto A, Kharma B, Kosaka K, Konishi I. PD-L1 on Tumor Cells Is Induced in Ascites and Promotes Peritoneal Dissemination of Ovarian Cancer through CTL Dysfunction Abiko K, Mandai M, Hamanishi J, Yoshioka Y, Matsumura N, Baba T, Yamaguchi K, Murakami R, Yamamoto A, Kharma B, Kosaka K, Konishi I. PD-L1 on Tumor Cells Is Induced in Ascites and Promotes Peritoneal Dissemination of Ovarian Cancer through CTL Dysfunction Refereed Disclose to all
万代 昌紀 万代 昌紀 Suzuki A, Kariya M, Matsumura N, Baba T, Yagi H, Mandai M, Konishi I, Fujii S. Expression of p53 and p21(WAF-1), apoptosis, and proliferation of smooth muscle cells in normal myometrium during the menstrual cycle: implication of DNA damage and repair for Suzuki A, Kariya M, Matsumura N, Baba T, Yagi H, Mandai M, Konishi I, Fujii S. Expression of p53 and p21(WAF-1), apoptosis, and proliferation of smooth muscle cells in normal myometrium during the menstrual cycle: implication of DNA damage and repair for Refereed Disclose to all
万代 昌紀 万代 昌紀 Yamanoi K, Mandai M, Suzuki A, Matsumura N, Baba T, Yoshioka Y, Kosaka K, Konishi I. Synchronous primary corpus and ovarian cancer: High incidence of endometriosis and thrombosis Oncol Lett. 2012 Sep;4(3):375-380. Yamanoi K, Mandai M, Suzuki A, Matsumura N, Baba T, Yoshioka Y, Kosaka K, Konishi I. Synchronous primary corpus and ovarian cancer: High incidence of endometriosis and thrombosis Oncol Lett. 2012 Sep;4(3):375-380. Refereed Disclose to all
万代 昌紀 万代 昌紀 Ueda Y, Mandai M, Matsumura N, Baba T, Suzuki A, Yoshioka Y, Kosaka K, Konishi I. Adenoid cystic carcinoma of Skene’s glands: a rare origin in the female genital tract and the characteristic clinical course. Int J Gynecol Pathol. 2012 Nov;31(6):596-600. Ueda Y, Mandai M, Matsumura N, Baba T, Suzuki A, Yoshioka Y, Kosaka K, Konishi I. Adenoid cystic carcinoma of Skene’s glands: a rare origin in the female genital tract and the characteristic clinical course. Int J Gynecol Pathol. 2012 Nov;31(6):596-600. Refereed Disclose to all
万代 昌紀 万代 昌紀 Mandai M, Matsumura N, Kosaka K, Yasumoto K, Baba T, Yoshioka Y, Suzuki A, Konishi I. Laparoscopic tubo-ovarian transposition prior to chemoradiation for uterine cervical cancer Int J Case Rep Imag. 2012 3(6):42-45. Mandai M, Matsumura N, Kosaka K, Yasumoto K, Baba T, Yoshioka Y, Suzuki A, Konishi I. Laparoscopic tubo-ovarian transposition prior to chemoradiation for uterine cervical cancer Int J Case Rep Imag. 2012 3(6):42-45. Refereed Disclose to all
万代 昌紀 万代 昌紀 Yasumoto K, Suzuki A, Matsumura N, Baba T, Oiwa Y, Miyamoto S, Matsuura M, Obama K, Kido A, Umeoka S, Minamiguchi S, Mikami Y, Yoshioka Y, Kosaka K, Mandai M, Konishi I. Cancer risk and management in a womanwith Peutz-Jeghers syndrome. Int Canc Conf J. Yasumoto K, Suzuki A, Matsumura N, Baba T, Oiwa Y, Miyamoto S, Matsuura M, Obama K, Kido A, Umeoka S, Minamiguchi S, Mikami Y, Yoshioka Y, Kosaka K, Mandai M, Konishi I. Cancer risk and management in a womanwith Peutz-Jeghers syndrome. Int Canc Conf J. Refereed Disclose to all
万代 昌紀 万代 昌紀 Baba T, Su S, Umeoka S, Abiko K, Nakamoto Y, Mandai M, Matsumura N, Konishi I. Advanced extragonadal yolk sac tumor serially followed up with (18) F-fluorodexyglucose-positoron emission tomography and computerized tomography and serum alpha-fetoprotein. J Baba T, Su S, Umeoka S, Abiko K, Nakamoto Y, Mandai M, Matsumura N, Konishi I. Advanced extragonadal yolk sac tumor serially followed up with (18) F-fluorodexyglucose-positoron emission tomography and computerized tomography and serum alpha-fetoprotein. J Refereed Disclose to all
万代 昌紀 万代 昌紀 Mandai M, Suzuki A, Matsumura N, Baba T, Yamaguchi K, Hamanishi J, Yoshioka Y, Kosaka K, Konishi I Clinical management of ovarian endometriotic cyst (chocolate cyst)-diagnosis, medical treatment and minimal invasive surgery. Curr Obstet Gynecol Rep. 2012 Mandai M, Suzuki A, Matsumura N, Baba T, Yamaguchi K, Hamanishi J, Yoshioka Y, Kosaka K, Konishi I Clinical management of ovarian endometriotic cyst (chocolate cyst)-diagnosis, medical treatment and minimal invasive surgery. Curr Obstet Gynecol Rep. 2012 Refereed Disclose to all
万代 昌紀 万代 昌紀 Yamamura S, Matsumura N, Mandai M, Huang Z, Oura T, Baba T, Hamanishi J, Yamaguchi K, Kang HS, Okamoto T, Abiko K, Mori S, Murphy SK, Konishi I. The activated transforming growth factor-beta signaling pathway in peritoneal metastases is a potential therap Yamamura S, Matsumura N, Mandai M, Huang Z, Oura T, Baba T, Hamanishi J, Yamaguchi K, Kang HS, Okamoto T, Abiko K, Mori S, Murphy SK, Konishi I. The activated transforming growth factor-beta signaling pathway in peritoneal metastases is a potential therap Refereed Disclose to all
万代 昌紀 万代 昌紀 Taki M, Baba T, Mandai M, Suzuki A, Mikami Y, Matsumura N, Konishi I A case of solitary fibrous tumor arising slowly in vulva over 10 years – case report and review. J Obstet Gynaecol Res. 2012 May;38(5):884-8. Taki M, Baba T, Mandai M, Suzuki A, Mikami Y, Matsumura N, Konishi I A case of solitary fibrous tumor arising slowly in vulva over 10 years – case report and review. J Obstet Gynaecol Res. 2012 May;38(5):884-8. Refereed Disclose to all
万代 昌紀 万代 昌紀 Hamanishi J, Mandai M, Abiko K, Matsumura N, Baba T, Yoshioka Y, Kosaka K, Konishi I The comprehensive assessment of local immune status of ovarian cancer by the clustering of multiple immune factors. Clin Immunol 2011 Dec;141(3):338-47. Hamanishi J, Mandai M, Abiko K, Matsumura N, Baba T, Yoshioka Y, Kosaka K, Konishi I The comprehensive assessment of local immune status of ovarian cancer by the clustering of multiple immune factors. Clin Immunol 2011 Dec;141(3):338-47. Refereed Disclose to all
万代 昌紀 万代 昌紀 Mandai M, Matsumura N, Baba T, Yamaguchi K, Hamanishi J, Konishi I. Ovarian clear cell carcinoma as a stress-responsive cancer: influence of the microenvironment on the carcinogenesis and cancer phenotype. Cancer Lett. 2011 Nov 28;310(2):129-33. Mandai M, Matsumura N, Baba T, Yamaguchi K, Hamanishi J, Konishi I. Ovarian clear cell carcinoma as a stress-responsive cancer: influence of the microenvironment on the carcinogenesis and cancer phenotype. Cancer Lett. 2011 Nov 28;310(2):129-33. Refereed Disclose to all
万代 昌紀 万代 昌紀 Satoh H, Baba T, Mandai M, Suzuki A, Matsumura N, Konishi I. Primary squamous cell carcinoma of fallopian tube accompanied by gastric metaplasia of female genital tract: Case report and review. J Obstet Gynaecol Res. 2011 Aug;37(8):1106-11. Satoh H, Baba T, Mandai M, Suzuki A, Matsumura N, Konishi I. Primary squamous cell carcinoma of fallopian tube accompanied by gastric metaplasia of female genital tract: Case report and review. J Obstet Gynaecol Res. 2011 Aug;37(8):1106-11. Refereed Disclose to all
万代 昌紀 万代 昌紀 Baba T, Mandai M, Yamanishi Y, Suzuki A, Kang HS, Konishi I. Endometrial cancer implanted within a cesarean section scar. J Obstet Gynaecol Res. 2011 Mar;37(3):245-9. Baba T, Mandai M, Yamanishi Y, Suzuki A, Kang HS, Konishi I. Endometrial cancer implanted within a cesarean section scar. J Obstet Gynaecol Res. 2011 Mar;37(3):245-9. Refereed Disclose to all
万代 昌紀 万代 昌紀 Kang HS, Baba T, Mandai M, Matsumura N, Hamanishi J, Kharma B, Kondoh E, Yoshioka Y, Oishi S, Fujii N, Murphy SK, Konishi I. GPR54 is a target for suppression of metastasis in endometrial cancer. Mol Cancer Ther. 2011 Apr;10(4):580-90. Kang HS, Baba T, Mandai M, Matsumura N, Hamanishi J, Kharma B, Kondoh E, Yoshioka Y, Oishi S, Fujii N, Murphy SK, Konishi I. GPR54 is a target for suppression of metastasis in endometrial cancer. Mol Cancer Ther. 2011 Apr;10(4):580-90. Refereed Disclose to all
万代 昌紀 万代 昌紀 Okamoto T, Matsumura N, Mandai M, Oura T, Yamanishi Y, Horiuchi A, Hamanishi J, Baba T, Koshiyama M, Shiozawa T, Konishi I. Distinguishing primary from secondary mucinous ovarian tumors: an algorithm using the novel marker DPEP1. Mod Pathol. 2011 Feb;24(2 Okamoto T, Matsumura N, Mandai M, Oura T, Yamanishi Y, Horiuchi A, Hamanishi J, Baba T, Koshiyama M, Shiozawa T, Konishi I. Distinguishing primary from secondary mucinous ovarian tumors: an algorithm using the novel marker DPEP1. Mod Pathol. 2011 Feb;24(2 Refereed Disclose to all
万代 昌紀 万代 昌紀 Matsumura N, Mandai M, Okamoto T, Yamaguchi K, Yamamura S, Oura T, Baba T, Hamanishi J, Kang HS, Matsui S, Mori S, Murphy SK, Konishi I. Sorafenib efficacy in ovarian clear cell carcinoma revealed by transcriptome profiling. Cancer Sci. 2010 Dec;101(12):2 Matsumura N, Mandai M, Okamoto T, Yamaguchi K, Yamamura S, Oura T, Baba T, Hamanishi J, Kang HS, Matsui S, Mori S, Murphy SK, Konishi I. Sorafenib efficacy in ovarian clear cell carcinoma revealed by transcriptome profiling. Cancer Sci. 2010 Dec;101(12):2 Refereed Disclose to all
万代 昌紀 万代 昌紀 Mandai M, Hamanishi J, Abiko K, Matsumura N, Baba T, Yoshioka Y, Konishi I. Suppression of metastatic murine ovarian cancer cells by transduced embryonic progenitor cells. Horm Cancer. 2010 Dec;1(6):291-6. Mandai M, Hamanishi J, Abiko K, Matsumura N, Baba T, Yoshioka Y, Konishi I. Suppression of metastatic murine ovarian cancer cells by transduced embryonic progenitor cells. Horm Cancer. 2010 Dec;1(6):291-6. Refereed Disclose to all
万代 昌紀 万代 昌紀 Abiko K, Mandai M, Hamanishi J, Matsumura N, Baba T, Horiuchi A, Mikami Y, Yoshioka S, Wakasa T, Shiozawa T, Konishi I. Oct4 expression in immature teratoma of the ovary: relevance to histologic grade and degree of differentiation. Am J Surg Pathol. 2010 Abiko K, Mandai M, Hamanishi J, Matsumura N, Baba T, Horiuchi A, Mikami Y, Yoshioka S, Wakasa T, Shiozawa T, Konishi I. Oct4 expression in immature teratoma of the ovary: relevance to histologic grade and degree of differentiation. Am J Surg Pathol. 2010 Refereed Disclose to all
万代 昌紀 万代 昌紀 Yamaguchi K, Mandai M, Oura T, Matsumura N, Hamanishi J, Baba T, Matsui S, Murphy SK, Konishi I. Identification of an ovarian clear cell carcinoma gene signature that reflects inherent disease biology and the carcinogenic processes. Oncogene. 2010 Mar 25; Yamaguchi K, Mandai M, Oura T, Matsumura N, Hamanishi J, Baba T, Matsui S, Murphy SK, Konishi I. Identification of an ovarian clear cell carcinoma gene signature that reflects inherent disease biology and the carcinogenic processes. Oncogene. 2010 Mar 25; Refereed Disclose to all
万代 昌紀 万代 昌紀 Abiko K, Baba T, Ogawa M, Mikami Y, Koyama T, Mandai M, Konishi I. Minimal deviation mucinous adenocarcinoma ('adenoma malignum') of the uterine corpus. Pathol Int. 2010 Jan;60(1):42-7. Abiko K, Baba T, Ogawa M, Mikami Y, Koyama T, Mandai M, Konishi I. Minimal deviation mucinous adenocarcinoma ('adenoma malignum') of the uterine corpus. Pathol Int. 2010 Jan;60(1):42-7. Refereed Disclose to all
万代 昌紀 万代 昌紀 Hamanishi J, Mandai M, Matsumura N, Baba T, Yamaguchi K, Fujii S, Konishi I. Activated local immunity by CC chemokine ligand 19-transduced embryonic endothelial progenitor cells suppresses metastasis of murine ovarian cancer. Stem Cells. 2010 Jan;28(1):16 Hamanishi J, Mandai M, Matsumura N, Baba T, Yamaguchi K, Fujii S, Konishi I. Activated local immunity by CC chemokine ligand 19-transduced embryonic endothelial progenitor cells suppresses metastasis of murine ovarian cancer. Stem Cells. 2010 Jan;28(1):16 Refereed Disclose to all
万代 昌紀 万代 昌紀 Konishi I, Mandai M, Kuroda H, Horiuchi A, Itoh K, Rao, C.V., Chapter 18. Infertility and ovarian cancer; a review. Gonadal and Nongonadal Actions of Gonadotropins, Edit. Anand Kumar et al, Narosa Publishing House, New Delhi, India, 2009 Konishi I, Mandai M, Kuroda H, Horiuchi A, Itoh K, Rao, C.V., Chapter 18. Infertility and ovarian cancer; a review. Gonadal and Nongonadal Actions of Gonadotropins, Edit. Anand Kumar et al, Narosa Publishing House, New Delhi, India, 2009 Refereed Disclose to all
万代 昌紀 万代 昌紀 Mandai M, Yamaguchi K, Matsumura N, Baba T, Konishi I. Ovarian cancer in endometriosis: molecular biology, pathology, and clinical management. Int J Clin Oncol. 2009 Oct;14(5):383-91. Mandai M, Yamaguchi K, Matsumura N, Baba T, Konishi I. Ovarian cancer in endometriosis: molecular biology, pathology, and clinical management. Int J Clin Oncol. 2009 Oct;14(5):383-91. Refereed Disclose to all
万代 昌紀 万代 昌紀 Li K, Mandai M, Hamanishi J, Matsumura N, Suzuki A, Yagi H, Yamaguchi K, Baba T, Fujii S, Konishi I. Clinical significance of the NKG2D ligands, MICA/B and ULBP2 in ovarian cancer: high expression of ULBP2 is an indicator of poor prognosis. Cancer Immunol Li K, Mandai M, Hamanishi J, Matsumura N, Suzuki A, Yagi H, Yamaguchi K, Baba T, Fujii S, Konishi I. Clinical significance of the NKG2D ligands, MICA/B and ULBP2 in ovarian cancer: high expression of ULBP2 is an indicator of poor prognosis. Cancer Immunol Refereed Disclose to all
万代 昌紀 万代 昌紀 Liu M, Matsumura N, Mandai M, Li K, Yagi H, Baba T, Suzuki A, Hamanishi J, Fukuhara K, Konishi I. Classification using hierarchical clustering of tumor-infiltrating immune cells identifies poor prognostic ovarian cancers with high levels of COX expression Liu M, Matsumura N, Mandai M, Li K, Yagi H, Baba T, Suzuki A, Hamanishi J, Fukuhara K, Konishi I. Classification using hierarchical clustering of tumor-infiltrating immune cells identifies poor prognostic ovarian cancers with high levels of COX expression Refereed Disclose to all
万代 昌紀 万代 昌紀 Yamaguchi K, Mandai M, Fukuhara K, Higuchi T, Hamanishi J, Takakura K, Fujii S. Malignant transformation of mature cystic teratoma of the ovary including three cases occurring during follow-up period. Oncol Rep. 2008 Mar;19(3):705-11. Yamaguchi K, Mandai M, Fukuhara K, Higuchi T, Hamanishi J, Takakura K, Fujii S. Malignant transformation of mature cystic teratoma of the ovary including three cases occurring during follow-up period. Oncol Rep. 2008 Mar;19(3):705-11. Refereed Disclose to all
万代 昌紀 万代 昌紀 Yamaguchi K, Mandai M, Toyokuni S, Hamanishi J, Higuchi T, Takakura K, Fujii S. Contents of endometriotic cysts, especially the high concentration of free iron, are a possible cause of carcinogenesis in the cysts through the iron-induced persistent oxidat Yamaguchi K, Mandai M, Toyokuni S, Hamanishi J, Higuchi T, Takakura K, Fujii S. Contents of endometriotic cysts, especially the high concentration of free iron, are a possible cause of carcinogenesis in the cysts through the iron-induced persistent oxidat Refereed Disclose to all
万代 昌紀 万代 昌紀 Hamanishi J, Higuchi T, Mandai M, Fukuhara K, An M, Nakayama T, Takakura K, Fujii S. Intractable recurrent cervical cancer with pelvic bone involvement successfully treated with external hemipelvectomy. J Obstet Gynaecol Res. 2008 Feb;34(1):112-6. Hamanishi J, Higuchi T, Mandai M, Fukuhara K, An M, Nakayama T, Takakura K, Fujii S. Intractable recurrent cervical cancer with pelvic bone involvement successfully treated with external hemipelvectomy. J Obstet Gynaecol Res. 2008 Feb;34(1):112-6. Refereed Disclose to all
万代 昌紀 万代 昌紀 Matsumura N, Mandai M, Hamanishi J, Yamaguchi K, Fukuhara K, Yagi H, Higuchi T, Takakura K, Fujii S. Immunostimulatory effect of Fms-like tyrosine kinase 3 ligand on peripheral monocyte-derived dendritic cells and natural killer cells: utilization for ov Matsumura N, Mandai M, Hamanishi J, Yamaguchi K, Fukuhara K, Yagi H, Higuchi T, Takakura K, Fujii S. Immunostimulatory effect of Fms-like tyrosine kinase 3 ligand on peripheral monocyte-derived dendritic cells and natural killer cells: utilization for ov Refereed Disclose to all
万代 昌紀 万代 昌紀 Fujii S, Takakura K, Matsumura N, Higuchi T, Yura S, Mandai M, Baba T, Yoshioka S. Anatomic identification and functional outcomes of the nerve sparing Okabayashi radical hysterectomy. Gynecol Oncol. 2007 Oct;107(1):4-13. Fujii S, Takakura K, Matsumura N, Higuchi T, Yura S, Mandai M, Baba T, Yoshioka S. Anatomic identification and functional outcomes of the nerve sparing Okabayashi radical hysterectomy. Gynecol Oncol. 2007 Oct;107(1):4-13. Refereed Disclose to all
万代 昌紀 万代 昌紀 Baba T, Mori S, Matsumura N, Kariya M, Murphy SK, Kondoh E, Kusakari T, Kuroda H, Mandai M, Higuchi T, Takakura K, Fukuda MN, Fujii S. Trophinin is a potent prognostic marker of ovarian cancer involved in platinum sensitivity. Biochem Biophys Res Commun. Baba T, Mori S, Matsumura N, Kariya M, Murphy SK, Kondoh E, Kusakari T, Kuroda H, Mandai M, Higuchi T, Takakura K, Fukuda MN, Fujii S. Trophinin is a potent prognostic marker of ovarian cancer involved in platinum sensitivity. Biochem Biophys Res Commun. Refereed Disclose to all
万代 昌紀 万代 昌紀 Baba T, Kariya M, Higuchi T, Mandai M, Matsumura N, Kondoh E, Miyanishi M, Fukuhara K, Takakura K, Fujii S. Neuropilin-1 promotes unlimited growth of ovarian cancer by evading contact inhibition. Gynecol Oncol. 2007 Jun;105(3):703-11. Baba T, Kariya M, Higuchi T, Mandai M, Matsumura N, Kondoh E, Miyanishi M, Fukuhara K, Takakura K, Fujii S. Neuropilin-1 promotes unlimited growth of ovarian cancer by evading contact inhibition. Gynecol Oncol. 2007 Jun;105(3):703-11. Refereed Disclose to all
万代 昌紀 万代 昌紀 Hamanishi J, Mandai M, Iwasaki M, Okazaki T, Tanaka Y, Yamaguchi K, Higuchi T, Yagi H, Takakura K, Minato N, Honjo T, Fujii S. Programmed cell death 1 ligand 1 and tumor-infiltrating CD8+ T lymphocytes are prognostic factors of human ovarian cancer. Pro Hamanishi J, Mandai M, Iwasaki M, Okazaki T, Tanaka Y, Yamaguchi K, Higuchi T, Yagi H, Takakura K, Minato N, Honjo T, Fujii S. Programmed cell death 1 ligand 1 and tumor-infiltrating CD8+ T lymphocytes are prognostic factors of human ovarian cancer. Pro Refereed Disclose to all
万代 昌紀 万代 昌紀 Mandai M, Konishi I, Kuroda H, Fujii S. LH/hCG action and development of ovarian cancer--a short review on biological and clinical/epidemiological aspects. Mol Cell Endocrinol. 2007 Apr 15;269(1-2):61-4. Mandai M, Konishi I, Kuroda H, Fujii S. LH/hCG action and development of ovarian cancer--a short review on biological and clinical/epidemiological aspects. Mol Cell Endocrinol. 2007 Apr 15;269(1-2):61-4. Refereed Disclose to all
万代 昌紀 万代 昌紀 Miyanishi M, Mandai M, Matsumura N, Yamaguchi K, Hamanishi J, Higuchi T, Takakura K, Fujii S. Immortalized ovarian surface epithelial cells acquire tumorigenicity by Acrogranin gene overexpression. Oncol Rep. 2007 Feb;17(2):329-33. Miyanishi M, Mandai M, Matsumura N, Yamaguchi K, Hamanishi J, Higuchi T, Takakura K, Fujii S. Immortalized ovarian surface epithelial cells acquire tumorigenicity by Acrogranin gene overexpression. Oncol Rep. 2007 Feb;17(2):329-33. Refereed Disclose to all
万代 昌紀 万代 昌紀 Fujii S, Takakura K, Matsumura N, Higuchi T, Yura S, Mandai M, Baba T. Precise anatomy of the vesico-uterine ligament for radical hysterectomy. Gynecol Oncol. 2007 Jan;104(1):186-91. Fujii S, Takakura K, Matsumura N, Higuchi T, Yura S, Mandai M, Baba T. Precise anatomy of the vesico-uterine ligament for radical hysterectomy. Gynecol Oncol. 2007 Jan;104(1):186-91. Refereed Disclose to all
万代 昌紀 万代 昌紀 Chen TH, Fukuhara K, Mandai M, Matsumura N, Kariya M, Takakura K, Fujii S. Increased cyclooxygenase-2 expression is correlated with suppressed antitumor immunity in cervical adenocarcinomas. Int J Gynecol Cancer. 2006 Mar-Apr;16(2):772-9. Chen TH, Fukuhara K, Mandai M, Matsumura N, Kariya M, Takakura K, Fujii S. Increased cyclooxygenase-2 expression is correlated with suppressed antitumor immunity in cervical adenocarcinomas. Int J Gynecol Cancer. 2006 Mar-Apr;16(2):772-9. Refereed Disclose to all
万代 昌紀 万代 昌紀 Ohashi M, Kobayashi A, Hara H, Miura Y, Yoshida K, Kushida M, Ikarashi Y, Mandai M, Kitajima M, Yoshida T, Aoki K. Allogeneic MHC gene transfer enhances antitumor activity of allogeneic hematopoietic stem cell transplantation without exacerbating graft-v Ohashi M, Kobayashi A, Hara H, Miura Y, Yoshida K, Kushida M, Ikarashi Y, Mandai M, Kitajima M, Yoshida T, Aoki K. Allogeneic MHC gene transfer enhances antitumor activity of allogeneic hematopoietic stem cell transplantation without exacerbating graft-v Refereed Disclose to all
万代 昌紀 万代 昌紀 Matsumoto A, Higuchi T, Yura S, Mandai M, Kariya M, Takakura K, Fujii S. Role of salvage cytoreductive surgery in the treatment of patients with recurrent ovarian cancer after platinum-based chemotherapy. J Obstet Gynaecol Res. 2006 Dec;32(6):580-7. Matsumoto A, Higuchi T, Yura S, Mandai M, Kariya M, Takakura K, Fujii S. Role of salvage cytoreductive surgery in the treatment of patients with recurrent ovarian cancer after platinum-based chemotherapy. J Obstet Gynaecol Res. 2006 Dec;32(6):580-7. Refereed Disclose to all
万代 昌紀 万代 昌紀 Matsumura N, Mandai M, Miyanishi M, Fukuhara K, Baba T, Higuchi T, Kariya M, Takakura K, Fujii S. Oncogenic property of acrogranin in human uterine leiomyosarcoma: direct evidence of genetic contribution in in vivo tumorigenesis. Clin Cancer Res. 2006 Ma Matsumura N, Mandai M, Miyanishi M, Fukuhara K, Baba T, Higuchi T, Kariya M, Takakura K, Fujii S. Oncogenic property of acrogranin in human uterine leiomyosarcoma: direct evidence of genetic contribution in in vivo tumorigenesis. Clin Cancer Res. 2006 Ma Refereed Disclose to all
万代 昌紀 万代 昌紀 Konishi M, Tabata Y, Kariya M, Hosseinkhani H, Suzuki A, Fukuhara K, Mandai M, Takakura K, Fujii S. In vivo anti-tumor effect of dual release of cisplatin and adriamycin from biodegradable gelatin hydrogel. J Control Release. 2005 Mar 2;103(1):7-19. Konishi M, Tabata Y, Kariya M, Hosseinkhani H, Suzuki A, Fukuhara K, Mandai M, Takakura K, Fujii S. In vivo anti-tumor effect of dual release of cisplatin and adriamycin from biodegradable gelatin hydrogel. J Control Release. 2005 Mar 2;103(1):7-19. Refereed Disclose to all
万代 昌紀 万代 昌紀 Kanamori T, Takakura K, Mandai M, Kariya M, Fukuhara K, Sakaguchi M, Huh NH, Saito K, Sakurai T, Fujita J, Fujii S. Increased expression of calcium-binding protein S100 in human uterine smooth muscle tumours. Mol Hum Reprod. 2004 Oct;10(10):735-42. Kanamori T, Takakura K, Mandai M, Kariya M, Fukuhara K, Sakaguchi M, Huh NH, Saito K, Sakurai T, Fujita J, Fujii S. Increased expression of calcium-binding protein S100 in human uterine smooth muscle tumours. Mol Hum Reprod. 2004 Oct;10(10):735-42. Refereed Disclose to all
万代 昌紀 万代 昌紀 Mandai M. Krukenberg tumors. CME Journal of Gynecologic Oncology 2004 July, 9(10):125-128. Mandai M. Krukenberg tumors. CME Journal of Gynecologic Oncology 2004 July, 9(10):125-128. Refereed Disclose to all
万代 昌紀 万代 昌紀 Kusakari T, Kariya M, Mandai M, Tsuruta Y, Hamid AA, Fukuhara K, Nanbu K, Takakura K, Fujii S. C-erbB-2 or mutant Ha-ras induced malignant transformation of immortalized human ovarian surface epithelial cells in vitro. Br J Cancer. 2003 Dec 15;89(12):229 Kusakari T, Kariya M, Mandai M, Tsuruta Y, Hamid AA, Fukuhara K, Nanbu K, Takakura K, Fujii S. C-erbB-2 or mutant Ha-ras induced malignant transformation of immortalized human ovarian surface epithelial cells in vitro. Br J Cancer. 2003 Dec 15;89(12):229 Refereed Disclose to all
万代 昌紀 万代 昌紀 Konishi M, Tabata Y, Kariya M, Suzuki A, Mandai M, Nanbu K, Takakura K, Fujii S. In vivo anti-tumor effect through the controlled release of cisplatin from biodegradable gelatin hydrogel. J Control Release. 2003 Oct 30;92(3):301-13. Konishi M, Tabata Y, Kariya M, Suzuki A, Mandai M, Nanbu K, Takakura K, Fujii S. In vivo anti-tumor effect through the controlled release of cisplatin from biodegradable gelatin hydrogel. J Control Release. 2003 Oct 30;92(3):301-13. Refereed Disclose to all
万代 昌紀 万代 昌紀 Kanamori T, Takakura K, Mandai M, Kariya M, Fukuhara K, Kusakari T, Momma C, Shime H, Yagi H, Konishi M, Suzuki A, Matsumura N, Nanbu K, Fujita J, Fujii S. PEP-19 overexpression in human uterine leiomyoma. Mol Hum Reprod. 2003 Nov;9(11):709-17. Kanamori T, Takakura K, Mandai M, Kariya M, Fukuhara K, Kusakari T, Momma C, Shime H, Yagi H, Konishi M, Suzuki A, Matsumura N, Nanbu K, Fujita J, Fujii S. PEP-19 overexpression in human uterine leiomyoma. Mol Hum Reprod. 2003 Nov;9(11):709-17. Refereed Disclose to all
万代 昌紀 万代 昌紀 Yura Y, Mandai M, Konishi I, Hamid AA, Tsuruta Y, Kusakari T, Fujii S. Loss of Fhit protein expression in high-grade and advanced stage endometrial carcinomas. Anticancer Res. 2003 May-Jun;23(3C):2837-43. Yura Y, Mandai M, Konishi I, Hamid AA, Tsuruta Y, Kusakari T, Fujii S. Loss of Fhit protein expression in high-grade and advanced stage endometrial carcinomas. Anticancer Res. 2003 May-Jun;23(3C):2837-43. Refereed Disclose to all
万代 昌紀 万代 昌紀 Hamid AA, Mandai M, Fujita J, Nanbu K, Kariya M, Kusakari T, Fukuhara K, Fujii S. Expression of cold-inducible RNA-binding protein in the normal endometrium, endometrial hyperplasia, and endometrial carcinoma. Int J Gynecol Pathol. 2003 Jul;22(3):240-7. Hamid AA, Mandai M, Fujita J, Nanbu K, Kariya M, Kusakari T, Fukuhara K, Fujii S. Expression of cold-inducible RNA-binding protein in the normal endometrium, endometrial hyperplasia, and endometrial carcinoma. Int J Gynecol Pathol. 2003 Jul;22(3):240-7. Refereed Disclose to all
万代 昌紀 万代 昌紀 Hamid AA, Mandai M, Konishi I, Nanbu K, Tsuruta Y, Kusakari T, Kariya M, Kita M, Fujii S. Cyclical change of hMSH2 protein expression in normal endometrium during the menstrual cycle and its overexpression in endometrial hyperplasia and sporadic endometr Hamid AA, Mandai M, Konishi I, Nanbu K, Tsuruta Y, Kusakari T, Kariya M, Kita M, Fujii S. Cyclical change of hMSH2 protein expression in normal endometrium during the menstrual cycle and its overexpression in endometrial hyperplasia and sporadic endometr Refereed Disclose to all
万代 昌紀 万代 昌紀 Mandai M, Konishi I, Tsuruta Y, Suginami N, Kusakari T, Iwasaki T, Fujii S. Krukenberg tumor from an occult appendiceal adenocarcinoid: a case report and review of the literature. Eur J Obstet Gynecol Reprod Biol. 2001 Jul;97(1):90-5. Review. Mandai M, Konishi I, Tsuruta Y, Suginami N, Kusakari T, Iwasaki T, Fujii S. Krukenberg tumor from an occult appendiceal adenocarcinoid: a case report and review of the literature. Eur J Obstet Gynecol Reprod Biol. 2001 Jul;97(1):90-5. Review. Refereed Disclose to all
万代 昌紀 万代 昌紀 Nakamoto Y, Saga T, Ishimori T, Mamede M, Togashi K, Higuchi T, Mandai M, Fujii S, Sakahara H, Konishi J. Clinical value of positron emission tomography with FDG for recurrent ovarian cancer. AJR Am J Roentgenol. 2001 Jun;176(6):1449-54. Nakamoto Y, Saga T, Ishimori T, Mamede M, Togashi K, Higuchi T, Mandai M, Fujii S, Sakahara H, Konishi J. Clinical value of positron emission tomography with FDG for recurrent ovarian cancer. AJR Am J Roentgenol. 2001 Jun;176(6):1449-54. Refereed Disclose to all
万代 昌紀 万代 昌紀 Tsuruta Y, Mandai M, Konishi I, Kuroda H, Kusakari T, Yura Y, Hamid AA, Tamura I, Kariya M, Fujii S. Combination effect of adenovirus-mediated pro-apoptotic bax gene transfer with cisplatin or paclitaxel treatment in ovarian cancer cell lines. Eur J Canc Tsuruta Y, Mandai M, Konishi I, Kuroda H, Kusakari T, Yura Y, Hamid AA, Tamura I, Kariya M, Fujii S. Combination effect of adenovirus-mediated pro-apoptotic bax gene transfer with cisplatin or paclitaxel treatment in ovarian cancer cell lines. Eur J Canc Refereed Disclose to all
万代 昌紀 万代 昌紀 Kuroda H, Mandai M, Konishi I, Tsuruta Y, Kusakari T, Kariya M, Fujii S. Human ovarian surface epithelial (OSE) cells express LH/hCG receptors, and hCG inhibits apoptosis of OSE cells via up-regulation of insulin-like growth factor-1. Int J Cancer. 2001 Kuroda H, Mandai M, Konishi I, Tsuruta Y, Kusakari T, Kariya M, Fujii S. Human ovarian surface epithelial (OSE) cells express LH/hCG receptors, and hCG inhibits apoptosis of OSE cells via up-regulation of insulin-like growth factor-1. Int J Cancer. 2001 Refereed Disclose to all
万代 昌紀 万代 昌紀 Konishi I, Kuroda H, Mandai M. Review: gonadotropins and development of ovarian cancer. Oncology. 1999 Oct;57 Suppl 2:45-8. Review. Konishi I, Kuroda H, Mandai M. Review: gonadotropins and development of ovarian cancer. Oncology. 1999 Oct;57 Suppl 2:45-8. Review. Refereed Disclose to all
万代 昌紀 万代 昌紀 Nanbu K, Konishi I, Mandai M, Kuroda H, Hamid AA, Komatsu T, Mori T. Prognostic significance of heat shock proteins HSP70 and HSP90 in endometrial carcinomas. Cancer Detect Prev. 1998;22(6):549-55. Nanbu K, Konishi I, Mandai M, Kuroda H, Hamid AA, Komatsu T, Mori T. Prognostic significance of heat shock proteins HSP70 and HSP90 in endometrial carcinomas. Cancer Detect Prev. 1998;22(6):549-55. Refereed Disclose to all
万代 昌紀 万代 昌紀 Konishi I, Nanbu K, Mandai M, Tsuruta Y, Kataoka N, Nagata Y, Mori T. Tumor response to neoadjuvant chemotherapy correlates with the expression of P-glycoprotein and PCNA but not GST-pi in the tumor cells of cervical carcinoma. Gynecol Oncol. 1998 Sep;70 Konishi I, Nanbu K, Mandai M, Tsuruta Y, Kataoka N, Nagata Y, Mori T. Tumor response to neoadjuvant chemotherapy correlates with the expression of P-glycoprotein and PCNA but not GST-pi in the tumor cells of cervical carcinoma. Gynecol Oncol. 1998 Sep;70 Refereed Disclose to all
万代 昌紀 万代 昌紀 Komatsu T, Konishi I, Mandai M, Mori T, Hiai H, Fukumoto M. Expression of class I human leukocyte antigen (HLA) and beta2-microglobulin is associated with decidualization of human endometrial stromal cells. Hum Reprod. 1998 Aug;13(8):2246-51. Komatsu T, Konishi I, Mandai M, Mori T, Hiai H, Fukumoto M. Expression of class I human leukocyte antigen (HLA) and beta2-microglobulin is associated with decidualization of human endometrial stromal cells. Hum Reprod. 1998 Aug;13(8):2246-51. Refereed Disclose to all
万代 昌紀 万代 昌紀 Mandai M, Konishi I, Kuroda H, Nanbu K, Matsushita K, Yura Y, Hamid AA, Mori T. Expression of abnormal transcripts of the FHIT (fragile histidine triad) gene in ovarian carcinoma. Eur J Cancer. 1998 Apr;34(5):745-9. Mandai M, Konishi I, Kuroda H, Nanbu K, Matsushita K, Yura Y, Hamid AA, Mori T. Expression of abnormal transcripts of the FHIT (fragile histidine triad) gene in ovarian carcinoma. Eur J Cancer. 1998 Apr;34(5):745-9. Refereed Disclose to all
万代 昌紀 万代 昌紀 Kuroda H, Mandai M, Konishi I, Yura Y, Tsuruta Y, Hamid AA, Nanbu K, Matsushita K, Mori T. Human chorionic gonadotropin (hCG) inhibits cisplatin-induced apoptosis in ovarian cancer cells: possible role of up-regulation of insulin-like growth factor-1 by Kuroda H, Mandai M, Konishi I, Yura Y, Tsuruta Y, Hamid AA, Nanbu K, Matsushita K, Mori T. Human chorionic gonadotropin (hCG) inhibits cisplatin-induced apoptosis in ovarian cancer cells: possible role of up-regulation of insulin-like growth factor-1 by Refereed Disclose to all
万代 昌紀 万代 昌紀 Yamamoto S, Konishi I, Tsuruta Y, Nanbu K, Mandai M, Kuroda H, Matsushita K, Hamid AA, Yura Y, Mori T. Expression of vascular endothelial growth factor (VEGF) during folliculogenesis and corpus luteum formation in the human ovary. Gynecol Endocrinol. 199 Yamamoto S, Konishi I, Tsuruta Y, Nanbu K, Mandai M, Kuroda H, Matsushita K, Hamid AA, Yura Y, Mori T. Expression of vascular endothelial growth factor (VEGF) during folliculogenesis and corpus luteum formation in the human ovary. Gynecol Endocrinol. 199 Refereed Disclose to all
万代 昌紀 万代 昌紀 Mandai M, Konishi I, Kuroda H, Komatsu T, Yamamoto S, Nanbu K, Matsushita K, Fukumoto M, Yamabe H, Mori T. Heterogeneous distribution of K-ras-mutated epithelia in mucinous ovarian tumors with special reference to histopathology. Hum Pathol. 1998 Jan;29( Mandai M, Konishi I, Kuroda H, Komatsu T, Yamamoto S, Nanbu K, Matsushita K, Fukumoto M, Yamabe H, Mori T. Heterogeneous distribution of K-ras-mutated epithelia in mucinous ovarian tumors with special reference to histopathology. Hum Pathol. 1998 Jan;29( Refereed Disclose to all
万代 昌紀 万代 昌紀 Yamamoto S, Konishi I, Mandai M, Kuroda H, Komatsu T, Nanbu K, Sakahara H, Mori T. Expression of vascular endothelial growth factor (VEGF) in epithelial ovarian neoplasms: correlation with clinicopathology and patient survival, and analysis of serum VEGF Yamamoto S, Konishi I, Mandai M, Kuroda H, Komatsu T, Nanbu K, Sakahara H, Mori T. Expression of vascular endothelial growth factor (VEGF) in epithelial ovarian neoplasms: correlation with clinicopathology and patient survival, and analysis of serum VEGF Refereed Disclose to all
万代 昌紀 万代 昌紀 Mandai M, Konishi I, Kuroda H, Fukumoto M, Komatsu T, Yamamoto S, Nanbu K, Rao CV, Mori T. Messenger ribonucleic acid expression of LH/hCG receptor gene in human ovarian carcinomas. Eur J Cancer. 1997 Aug;33(9):1501-7. Mandai M, Konishi I, Kuroda H, Fukumoto M, Komatsu T, Yamamoto S, Nanbu K, Rao CV, Mori T. Messenger ribonucleic acid expression of LH/hCG receptor gene in human ovarian carcinomas. Eur J Cancer. 1997 Aug;33(9):1501-7. Refereed Disclose to all
万代 昌紀 万代 昌紀 Yamamoto S, Konishi I, Nanbu K, Komatsu T, Mandai M, Kuroda H, Matsushita K, Mori T. Immunohistochemical localization of basic fibroblast growth factor (bFGF) during folliculogenesis in the human ovary. Gynecol Endocrinol. 1997 Aug;11(4):223-30. Yamamoto S, Konishi I, Nanbu K, Komatsu T, Mandai M, Kuroda H, Matsushita K, Mori T. Immunohistochemical localization of basic fibroblast growth factor (bFGF) during folliculogenesis in the human ovary. Gynecol Endocrinol. 1997 Aug;11(4):223-30. Refereed Disclose to all
万代 昌紀 万代 昌紀 Konishi I, Koshiyama M, Mandai M, Kuroda H, Yamamoto S, Nanbu K, Komatsu T, Matsushita K, Rao CV, Mori T. Increased expression of LH/hCG receptors in endometrial hyperplasia and carcinoma in anovulatory women. Gynecol Oncol. 1997 May;65(2):273-80. Konishi I, Koshiyama M, Mandai M, Kuroda H, Yamamoto S, Nanbu K, Komatsu T, Matsushita K, Rao CV, Mori T. Increased expression of LH/hCG receptors in endometrial hyperplasia and carcinoma in anovulatory women. Gynecol Oncol. 1997 May;65(2):273-80. Refereed Disclose to all
万代 昌紀 万代 昌紀 Komatsu T, Konishi I, Fukumoto M, Nanbu K, Koshiyama M, Mandai M, Mori T. Messenger ribonucleic acid expression of heat shock proteins HSP70 and HSP90 in human endometrium and myometrium during the menstrual cycle. J Clin Endocrinol Metab. 1997 May;82(5) Komatsu T, Konishi I, Fukumoto M, Nanbu K, Koshiyama M, Mandai M, Mori T. Messenger ribonucleic acid expression of heat shock proteins HSP70 and HSP90 in human endometrium and myometrium during the menstrual cycle. J Clin Endocrinol Metab. 1997 May;82(5) Refereed Disclose to all
万代 昌紀 万代 昌紀 Keitoku M, Konishi I, Nanbu K, Yamamoto S, Mandai M, Kataoka N, Oishi T, Mori T. Extraovarian sex cord-stromal tumor: case report and review of the literature. Int J Gynecol Pathol. 1997 Apr;16(2):180-5. Review. Keitoku M, Konishi I, Nanbu K, Yamamoto S, Mandai M, Kataoka N, Oishi T, Mori T. Extraovarian sex cord-stromal tumor: case report and review of the literature. Int J Gynecol Pathol. 1997 Apr;16(2):180-5. Review. Refereed Disclose to all
万代 昌紀 万代 昌紀 Kuroda H, Konishi I, Nanbu K, Mandai M, Komatsu T, Yamamoto S, Yamabe H, Kida A, Mori T. Malignant plexiform tumor of the uterus: an unusual variant of epithelioid leiomyosarcoma. Gynecol Oncol. 1996 Nov;63(2):270-5. Kuroda H, Konishi I, Nanbu K, Mandai M, Komatsu T, Yamamoto S, Yamabe H, Kida A, Mori T. Malignant plexiform tumor of the uterus: an unusual variant of epithelioid leiomyosarcoma. Gynecol Oncol. 1996 Nov;63(2):270-5. Refereed Disclose to all
万代 昌紀 万代 昌紀 Mandai M, Konishi I, Koshiyama M, Komatsu T, Yamamoto S, Nanbu K, Mori T, Fujii S. Ascitic positive cytology and intraperitoneal metastasis in ovarian dysgerminoma. J Obstet Gynaecol Res. 1996 Feb;22(1):89-94. Mandai M, Konishi I, Koshiyama M, Komatsu T, Yamamoto S, Nanbu K, Mori T, Fujii S. Ascitic positive cytology and intraperitoneal metastasis in ovarian dysgerminoma. J Obstet Gynaecol Res. 1996 Feb;22(1):89-94. Refereed Disclose to all
万代 昌紀 万代 昌紀 Nanbu K, Konishi I, Komatsu T, Mandai M, Yamamoto S, Kuroda H, Koshiyama M, Mori T. Expression of heat shock proteins HSP70 and HSP90 in endometrial carcinomas. Correlation with clinicopathology, sex steroid receptor status, and p53 protein expression. C Nanbu K, Konishi I, Komatsu T, Mandai M, Yamamoto S, Kuroda H, Koshiyama M, Mori T. Expression of heat shock proteins HSP70 and HSP90 in endometrial carcinomas. Correlation with clinicopathology, sex steroid receptor status, and p53 protein expression. C Refereed Disclose to all
万代 昌紀 万代 昌紀 Komatsu T, Konishi I, Mandai M, Togashi K, Kawakami S, Konishi J, Mori T. Adnexal masses: transvaginal US and gadolinium-enhanced MR imaging assessment of intratumoral structure. Radiology. 1996 Jan;198(1):109-15. Komatsu T, Konishi I, Mandai M, Togashi K, Kawakami S, Konishi J, Mori T. Adnexal masses: transvaginal US and gadolinium-enhanced MR imaging assessment of intratumoral structure. Radiology. 1996 Jan;198(1):109-15. Refereed Disclose to all
万代 昌紀 万代 昌紀 Mandai M, Konishi I, Komatsu T, Mori T, Arao S, Nomura H, Kanda Y, Hiai H, Fukumoto M. Mutation of the nm23 gene, loss of heterozygosity at the nm23 locus and K-ras mutation in ovarian carcinoma: correlation with tumour progression and nm23 gene expressi Mandai M, Konishi I, Komatsu T, Mori T, Arao S, Nomura H, Kanda Y, Hiai H, Fukumoto M. Mutation of the nm23 gene, loss of heterozygosity at the nm23 locus and K-ras mutation in ovarian carcinoma: correlation with tumour progression and nm23 gene expressi Refereed Disclose to all
万代 昌紀 万代 昌紀 Nanbu K, Konishi I, Yamamoto S, Koshiyama M, Mandai M, Komatsu T, Li W, Tokushige M, Higuchi K, Mori T. Minimal deviation adenocarcinoma of endometrioid type may arise in the isthmus: clinicopathological and immunohistochemical study of two cases. Gyneco Nanbu K, Konishi I, Yamamoto S, Koshiyama M, Mandai M, Komatsu T, Li W, Tokushige M, Higuchi K, Mori T. Minimal deviation adenocarcinoma of endometrioid type may arise in the isthmus: clinicopathological and immunohistochemical study of two cases. Gyneco Refereed Disclose to all
万代 昌紀 万代 昌紀 Mandai M, Konishi I, Koshiyama M, Komatsu T, Yamamoto S, Nanbu K, Mori T, Fukumoto M. Altered expression of nm23-H1 and c-erbB-2 proteins have prognostic significance in adenocarcinoma but not in squamous cell carcinoma of the uterine cervix. Cancer. 199 Mandai M, Konishi I, Koshiyama M, Komatsu T, Yamamoto S, Nanbu K, Mori T, Fukumoto M. Altered expression of nm23-H1 and c-erbB-2 proteins have prognostic significance in adenocarcinoma but not in squamous cell carcinoma of the uterine cervix. Cancer. 199 Refereed Disclose to all
万代 昌紀 万代 昌紀 Koshiyama M, Konishi I, Nanbu K, Nanbu Y, Mandai M, Komatsu T, Yamamoto S, Mori T, Fujii S. Immunohistochemical localization of heat shock proteins HSP70 and HSP90 in the human endometrium: correlation with sex steroid receptors and Ki-67 antigen express Koshiyama M, Konishi I, Nanbu K, Nanbu Y, Mandai M, Komatsu T, Yamamoto S, Mori T, Fujii S. Immunohistochemical localization of heat shock proteins HSP70 and HSP90 in the human endometrium: correlation with sex steroid receptors and Ki-67 antigen express Refereed Disclose to all
万代 昌紀 万代 昌紀 Komatsu T, Konishi I, Mandai M, Koshiyama M, Nanbu K, Yamamoto S, Kanzaki H, Rao CV, Mori T. Peritoneal papillary serous carcinoma arising in an infertile woman during ovulation-induction therapy: immunohistochemical expression of LH/hCG receptors. Gynec Komatsu T, Konishi I, Mandai M, Koshiyama M, Nanbu K, Yamamoto S, Kanzaki H, Rao CV, Mori T. Peritoneal papillary serous carcinoma arising in an infertile woman during ovulation-induction therapy: immunohistochemical expression of LH/hCG receptors. Gynec Refereed Disclose to all
万代 昌紀 万代 昌紀 Koshiyama M, Konishi I, Mandai M, Komatsu T, Yamamoto S, Nanbu K, Mori T. Immunohistochemical analysis of p53 protein and 72 kDa heat shock protein (HSP72) expression in ovarian carcinomas. Correlation with clinicopathology and sex steroid receptor statu Koshiyama M, Konishi I, Mandai M, Komatsu T, Yamamoto S, Nanbu K, Mori T. Immunohistochemical analysis of p53 protein and 72 kDa heat shock protein (HSP72) expression in ovarian carcinomas. Correlation with clinicopathology and sex steroid receptor statu Refereed Disclose to all
万代 昌紀 万代 昌紀 Konishi I, Ishikawa Y, Wang SY, Wang DP, Koshiyama M, Mandai M, Komatsu T, Yamamoto S, Mori T. Expression of transforming growth factor-alpha in the normal cervix and in benign and malignant lesions of the uterine cervix. Br J Obstet Gynaecol. 1994 Apr;1 Konishi I, Ishikawa Y, Wang SY, Wang DP, Koshiyama M, Mandai M, Komatsu T, Yamamoto S, Mori T. Expression of transforming growth factor-alpha in the normal cervix and in benign and malignant lesions of the uterine cervix. Br J Obstet Gynaecol. 1994 Apr;1 Refereed Disclose to all
万代 昌紀 万代 昌紀 Koshiyama M, Konishi I, Yoshida M, Wang DP, Mandai M, Mori T, Fujii S. Transitional cell carcinoma of the fallopian tube: a light and electron microscopic study. Int J Gynecol Pathol. 1994 Apr;13(2):175-80. Koshiyama M, Konishi I, Yoshida M, Wang DP, Mandai M, Mori T, Fujii S. Transitional cell carcinoma of the fallopian tube: a light and electron microscopic study. Int J Gynecol Pathol. 1994 Apr;13(2):175-80. Refereed Disclose to all
万代 昌紀 万代 昌紀 Mandai M, Konishi I, Koshiyama M, Mori T, Arao S, Tashiro H, Okamura H, Nomura H, Hiai H, Fukumoto M. Expression of metastasis-related nm23-H1 and nm23-H2 genes in ovarian carcinomas: correlation with clinicopathology, EGFR, c-erbB-2, and c-erbB-3 genes, Mandai M, Konishi I, Koshiyama M, Mori T, Arao S, Tashiro H, Okamura H, Nomura H, Hiai H, Fukumoto M. Expression of metastasis-related nm23-H1 and nm23-H2 genes in ovarian carcinomas: correlation with clinicopathology, EGFR, c-erbB-2, and c-erbB-3 genes, Refereed Disclose to all
万代 昌紀 万代 昌紀 Arao S, Suwa H, Mandai M, Tashiro H, Miyazaki K, Okamura H, Nomura H, Hiai H, Fukumoto M. Expression of multidrug resistance gene and localization of P-glycoprotein in human primary ovarian cancer. Cancer Res. 1994 Mar 1;54(5):1355-9. Arao S, Suwa H, Mandai M, Tashiro H, Miyazaki K, Okamura H, Nomura H, Hiai H, Fukumoto M. Expression of multidrug resistance gene and localization of P-glycoprotein in human primary ovarian cancer. Cancer Res. 1994 Mar 1;54(5):1355-9. Refereed Disclose to all
万代 昌紀 万代 昌紀 Wang D, Konishi I, Koshiyama M, Mandai M, Nanbu Y, Ishikawa Y, Mori T, Fujii S. Expression of c-erbB-2 protein and epidermal growth receptor in endometrial carcinomas. Correlation with clinicopathologic and sex steroid receptor status. Cancer. 1993 Nov 1 Wang D, Konishi I, Koshiyama M, Mandai M, Nanbu Y, Ishikawa Y, Mori T, Fujii S. Expression of c-erbB-2 protein and epidermal growth receptor in endometrial carcinomas. Correlation with clinicopathologic and sex steroid receptor status. Cancer. 1993 Nov 1 Refereed Disclose to all
万代 昌紀 万代 昌紀 Itoh H, Ihara Y, Hasegawa M, Okagaki A, Inamori K, Sagawa N, Mori T, Mandai M, Niwa H. Lupus anticoagulant (LAC) and its relation to pregnancy outcome: a report of five cases. Asia Oceania J Obstet Gynaecol. 1993 Mar;19(1):51-6. Itoh H, Ihara Y, Hasegawa M, Okagaki A, Inamori K, Sagawa N, Mori T, Mandai M, Niwa H. Lupus anticoagulant (LAC) and its relation to pregnancy outcome: a report of five cases. Asia Oceania J Obstet Gynaecol. 1993 Mar;19(1):51-6. Refereed Disclose to all
万代 昌紀 万代 昌紀 Koshiyama M, Konishi I, Wang DP, Mandai M, Komatsu T, Yamamoto S, Nanbu K, Naito MF, Mori T. Immunohistochemical analysis of p53 protein over-expression in endometrial carcinomas: inverse correlation with sex steroid receptor status. Virchows Arch A Path Koshiyama M, Konishi I, Wang DP, Mandai M, Komatsu T, Yamamoto S, Nanbu K, Naito MF, Mori T. Immunohistochemical analysis of p53 protein over-expression in endometrial carcinomas: inverse correlation with sex steroid receptor status. Virchows Arch A Path Refereed Disclose to all

  • <<
  • >>
Title language:
Misc
Author Author(Japanese) Author(English) Title Title(Japanese) Title(English) Bibliography Bibliography(Japanese) Bibliography(English) Publication date Refereed paper Language Publishing type Disclose
Ascitic positive cytology and intraperitoneal metastasis in ovarian dysgerminoma Ascitic positive cytology and intraperitoneal metastasis in ovarian dysgerminoma Ascitic positive cytology and intraperitoneal metastasis in ovarian dysgerminoma The Journal of Obstetrics and Gynecology Research, 22, 1, 89 The Journal of Obstetrics and Gynecology Research, 22, 1, 89 The Journal of Obstetrics and Gynecology Research, 22, 1, 89 1996 Disclose to all
M MANDAI, KONISHI, I, M KOSHIYAMA, T KOMATSU, S YAMAMOTO, K NANBU, T MORI, M FUKUMOTO M MANDAI, KONISHI, I, M KOSHIYAMA, T KOMATSU, S YAMAMOTO, K NANBU, T MORI, M FUKUMOTO M MANDAI, KONISHI, I, M KOSHIYAMA, T KOMATSU, S YAMAMOTO, K NANBU, T MORI, M FUKUMOTO ALTERED EXPRESSION OF NM23-H1 AND C-ERBB-2 PROTEINS HAVE PROGNOSTIC-SIGNIFICANCE IN ADENOCARCINOMA BUT NOT IN SQUAMOUS-CELL CARCINOMA OF THE UTERINE CERVIX ALTERED EXPRESSION OF NM23-H1 AND C-ERBB-2 PROTEINS HAVE PROGNOSTIC-SIGNIFICANCE IN ADENOCARCINOMA BUT NOT IN SQUAMOUS-CELL CARCINOMA OF THE UTERINE CERVIX ALTERED EXPRESSION OF NM23-H1 AND C-ERBB-2 PROTEINS HAVE PROGNOSTIC-SIGNIFICANCE IN ADENOCARCINOMA BUT NOT IN SQUAMOUS-CELL CARCINOMA OF THE UTERINE CERVIX CANCER, 75, 10, 2523-2529 CANCER, 75, 10, 2523-2529 CANCER, 75, 10, 2523-2529 1995/05 English Disclose to all
Mutation of the nm23 gene, loss of heterozygosity at the nm23 locus and K-ras mutation in ovarian carcinoma Mutation of the nm23 gene, loss of heterozygosity at the nm23 locus and K-ras mutation in ovarian carcinoma Mutation of the nm23 gene, loss of heterozygosity at the nm23 locus and K-ras mutation in ovarian carcinoma British Journal of Cancer, 72, 691 British Journal of Cancer, 72, 691 British Journal of Cancer, 72, 691 1995 Disclose to all
Expression of Metastasis-related nm23-H1 and nm23-H2 genes in ovarian carcinomas Expression of Metastasis-related nm23-H1 and nm23-H2 genes in ovarian carcinomas Expression of Metastasis-related nm23-H1 and nm23-H2 genes in ovarian carcinomas Cancer Research, 54, 1825 Cancer Research, 54, 1825 Cancer Research, 54, 1825 1994 Disclose to all
Title language:
Conference Activities & Talks
Title Title(Japanese) Title(English) Conference Conference(Japanese) Conference(English) Promotor Promotor(Japanese) Promotor(English) Date Language Assortment Disclose
MRIで診断し得た妊娠中の卵巣捻転の一例 MRIで診断し得た妊娠中の卵巣捻転の一例 JSAWI2013 JSAWI2013 JSAWI2013 JSAWI2013 2013/09 Disclose to all
Title language:
External funds: competitive funds and Grants-in-Aid for Scientific Research (Kakenhi)
Type Position Title(Japanese) Title(English) Period
基盤研究(C) 卵巣癌の腹腔内免疫環境と化学療法の相互作用の解析に基づいた免疫療法の構築 2009-2011
基盤研究(C) Representative 免疫賦活遺伝子を導入した血管内皮前駆細胞を用いた婦人科腫瘍の新生血管標的治療 -
挑戦的萌芽研究 Representative OMICS情報を臨床診療に反映するためのインターフェースとバーチャルカルテの開発 2013-2014
基盤研究(B) Representative 卵巣癌のゲノム多様性に基づく播種・転移・薬剤耐性・免疫逃避機序の解明と臨床応用 (平成29年度分) 2017/04/01-2018/03/31
挑戦的研究(萌芽) Representative 婦人科癌の包括的サポートプログラム開発を目指した患者モニタリング法の探索 (平成30年度分) 2018/04/01-2019/03/31
基盤研究(B) Representative 卵巣癌のゲノム多様性に基づく播種・転移・薬剤耐性・免疫逃避機序の解明と臨床応用 (平成30年度分) 2018/04/01-2019/03/31
挑戦的研究(萌芽) Representative 婦人科癌の包括的サポートプログラム開発を目指した患者モニタリング法の探索 (2019年度分) 2019/04/01-2020/03/31
External funds: other than those above
System Main person Title(Japanese) Title(English) Period
卵巣癌の発生・進展に関する研究 Study on Development and Progression of Ovarian Cancer -
卵巣癌の遺伝子治療に関する研究 Gene therapy on Ovarian Cancer -
Teaching subject(s)
Name(Japanese) Name(English) Term Department Period
生育医療学 後期 医学部 2011/04-
臨床外科疾病論Ⅱ 後期 医学部 2011/04-
生育医療学 Gynecologic and Pediatric Medicine 後期 医学部 2012/04-2013/03
臨床外科疾病論Ⅱ Clinical Overview of Surgery II 後期 医学部 2012/04-2013/03
S13・14 婦人科学・産科学 Gynecology and Obstetrics 前期 医学部 2017/04-2018/03
C10 産科学・婦人科学・女性腫瘍学 Gynecology and Obstetrics/Women Oncology 後期後半 医学部 2018/04-2019/03
S13・14 婦人科学・産科学 Gynecology and Obstetrics 前期 医学部 2018/04-2019/03
C10 産科学・婦人科学・女性腫瘍学 Gynecology and Obstetrics/Women Oncology 後期後半 医学部 2019/04-2020/03
S13・14 婦人科学・産科学 Gynecology and Obstetrics 前期 医学部 2019/04-2020/03
C10 産科学・婦人科学・女性腫瘍学 Gynecology and Obstetrics/Women Oncology 後期後半 医学部 2020/04-2021/03
S13・14 婦人科学・産科学 Gynecology and Obstetrics 前期 医学部 2020/04-2021/03

  • <<
  • >>
School management (title, position)
Title Period
オープンキャンパス委員会 委員 2019/01/01-2019/12/31
Faculty management (title, position)
Title Period
医学研究科運営委員会 2018/02/01-2019/05/31
人事連絡委員会 2019/04/01-2021/03/31
教授選考方針検討委員会外科系検討委員会 2018/11/01-2020/10/31
教授選考方針検討委員会中央診療部検討委員会 2018/11/01-2020/10/31